MiMedx Group, Inc. (MDXG)
4.12
-0.05
(-1.20%)
USD |
NASDAQ |
Mar 20, 16:00
4.13
+0.01
(+0.24%)
After-Hours: 20:00
MiMedx Group EPS Diluted (Quarterly) : 0.1012 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| ADMA Biologics, Inc. | 0.2025 |
| Viridian Therapeutics, Inc. | -1.080 |
| Arcus Biosciences, Inc. | -0.8945 |
| Mirum Pharmaceuticals, Inc. | -0.111 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.19M |
| Revenue (Quarterly) | 118.10M |
| Total Expenses (Quarterly) | 102.90M |
| Enterprise Value | 468.51M |
| Gross Profit Margin (Quarterly) | 83.76% |
| Profit Margin (Quarterly) | 12.86% |
| Earnings Yield | 7.87% |
| Operating Earnings Yield | 10.36% |
| Normalized Earnings Yield | 7.871 |